Literature DB >> 18508434

Chemokines in lupus nephritis.

Onkar Kulkarni1, Hans-Joachim Anders.   

Abstract

Lupus nephritis is a common solid organ manifestation of systemic lupus erythematosus (SLE). The disease is tightly linked to the production of autoantibodies and circulating immune complexes, i.e. immune complex glomerulonephritis. In this process chemokines mediate multiple biological effects, e.g. orchestrating proinflammatory microenvironments, the recruitment of immune cell subsets into the kidney, as well as the local activation of such immune effector cells. Autoimmune mice with targeted deletions of certain single chemokines or chemokine receptors are protected from renal autoimmune tissue injury. Interventional studies with specific antagonists against certain chemokines and chemokine receptors further support these findings. In this review we summarise the available experimental and human data on the expression and functional role of chemokines and chemokine receptors in lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508434     DOI: 10.2741/2927

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  21 in total

1.  The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis.

Authors:  Michael W Milks; James G Cripps; Heping Lin; Jing Wang; Richard T Robinson; Jennifer L Sargent; Michael L Whitfield; James D Gorham
Journal:  Liver Int       Date:  2009-04-16       Impact factor: 5.828

Review 2.  Immunopathology of lupus nephritis.

Authors:  Hans-Joachim Anders; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

3.  Functional characterization of peripheral blood dendritic cells and monocytes in systemic lupus erythematosus.

Authors:  Ana Henriques; Luís Inês; Tiago Carvalheiro; Maura Couto; Angela Andrade; Susana Pedreiro; Paula Laranjeira; José Mário Morgado; Maria Luísa Pais; José António Pereira da Silva; Artur Paiva
Journal:  Rheumatol Int       Date:  2011-01-08       Impact factor: 2.631

4.  Expression of Toll‑like receptors 3 and 9 in Egyptian systemic lupus erythematosus patients.

Authors:  A S Nasr; S M Fawzy; T A Gheita; E El-Khateeb
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

Review 5.  CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis - from bench to bedside?

Authors:  L Schiffer; K Worthmann; H Haller; M Schiffer
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

Review 6.  Biomarkers for renal disease in childhood.

Authors:  Lena Das; Hermine I Brunner
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

Review 7.  Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.

Authors:  E Kassi; P Moutsatsou
Journal:  J Biomed Biotechnol       Date:  2010-06-10

8.  Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.

Authors:  C K Wong; P T Y Wong; L S Tam; E K Li; D P Chen; C W K Lam
Journal:  Clin Exp Immunol       Date:  2009-10-16       Impact factor: 4.330

Review 9.  Why can't we find a new treatment for SLE?

Authors:  Robert Eisenberg
Journal:  J Autoimmun       Date:  2009-03-28       Impact factor: 7.094

Review 10.  The pathogenesis of lupus nephritis.

Authors:  Maciej Lech; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.